Shaff Eric D.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$1.32M

Insider Activity of Shaff Eric D.

According to the SEC Form 4 filings, Shaff Eric D., being in a position of

  1. CEO and President at Seres Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25054 shares for $28,422,
    over all time since 2016-03-28, has bought 0 shares, and sold 93468 shares for $1.32M.

The largest sale of all time was on 2016-03-31 and amounted to 15326 shares of Seres Therapeutics, Inc. for $403,139.

Biography of Shaff Eric D.

No biography is available at this moment.

2024-08-16SaleSeres Therapeutics, Inc.
MCRB
CEO and President
2,518
0.0015%
$0.84$2,1150%
2024-05-15SaleSeres Therapeutics, Inc.
MCRB
CEO and President
2,435
0.0016%
$0.94$2,289-3.98%
2024-02-16SaleSeres Therapeutics, Inc.
MCRB
CEO and President
11,549
0.0092%
$1.08$12,473-13.67%
2023-10-30SaleSeres Therapeutics, Inc.
MCRB
CEO and President
8,552
0.0062%
$1.35$11,545-29.66%
2019-01-28SaleSeres Therapeutics, Inc.
MCRB
See Remarks
4,378
0.0102%
$5.75$25,188-37.02%
2018-01-26SaleSeres Therapeutics, Inc.
MCRB
See Remarks
5,560
0.0137%
$11.02$61,271-27.31%
2016-06-30SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
9,066
0.0145%
$18.66$169,217-63.7%
2016-06-28SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
3,334
0.0083%
$28.85$96,186-64.17%
2016-06-27SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
6,668
0.0111%
$17.89$119,324-61.03%
2016-04-04SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
13,136
0.0215%
$18.32$240,652-59.75%
2016-03-31SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
15,326
0.0383%
$26.30$403,139-57.04%
2016-03-28SaleSeres Therapeutics, Inc.
MCRB
CFO and EVP
10,946
0.0182%
$15.93$174,370-53.21%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.